Signal active
Bio
David Tanen is a co-founder and Partner of Two River, where he has served as partner since its inception in 2004. David is also a Co-Founder of Kite Pharma, Inc., where he served as Corporate Secretary and General Counsel before its acquisition by Gilead Sciences in 2017. David is also a co-founder of Kronos Bio, Inc., and Neogene Therapeutics, Inc., each a privately held biotechnology company, where he serves as a member of the Board of Directors and Corporate Secretary. He is also a Co-Founder and Corporate Secretary of Allogene Therapeutics, Inc. (ALLO), an advisor to Vida Ventures, LLC, a life science investment firm. David received his B.A. from The George Washington University and his J.D. from Fordham University School of Law, where he has served on the Dean’s Planning Council since 2009.
Location
Flemington, New Jersey, United States, North America
Social
Primary Organization
2000
11-50
Biotechnology, Medical, Biopharma
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
David M. Tanen is the Co founder, Secretary & Director at Arno Therapeutics, based in United States, North America. With a background in Biotechnology, David M. Tanen has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.